In conclusion, the present study suggests that EGFR as well as HER2 mRNA overexpression are prognostic factors of worse clinical outcome in high-risk operable breast cancer patients, whereas HER3 and HER4 mRNA overexpression are both associated with a better prognosis. This evidence concerns the gene ERBB4 and breast cancer.